Market Cap 20.32B
Revenue (ttm) 2.07B
Net Income (ttm) 418.30M
EPS (ttm) N/A
PE Ratio 62.34
Forward PE 58.37
Profit Margin 20.19%
Debt to Equity Ratio 0.73
Volume 310,500
Avg Vol 679,382
Day's Range N/A - N/A
Shares Out 70.35M
Stochastic %K 27%
Beta 1.37
Analysts Strong Sell
Price Target $380.38

Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system...

Industry: Medical Devices
Sector: Healthcare
Phone: 978 600 7000
Address:
100 Nagog Park, Acton, United States
1iquid
1iquid Dec. 25 at 4:56 PM
💎 Liquid® Live Actionable Trade Asset: $PODD Contracts: $PODD December 18, 2026 $290 Calls Scale in: $43.72- $53.43 Scale out: $170.01-$291.45 Profit Potential : 209% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 1:59 PM
$PODD: Current market context shows a bearish trend with last close at $288.82 and an RSI of 23.42, indicating oversold conditions. The stock is trading below both the 30-day MA of $310.53 and the 50-day MA of $314.55, reinforcing the downward pressure. However, with a 60-day high of $354.88 and a low of $285.02, there’s potential for a rebound. Directional bias is cautiously bullish due to the extreme RSI, suggesting a possible reversal. Suggested entry: $290.00. Stop loss: $285.00 (below the 60D low). Take profit targets: 1. $310.00 (TP1, 6.9% ROI) 2. $320.00 (TP2, 10.1% ROI) 3. $338.00 (TP3, 17% ROI) This plan capitalizes on the potential for a bounce back from oversold conditions while maintaining a disciplined risk management approach. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 24 at 10:03 AM
$PODD Current Stock Price: $285.45 Contracts to trade: $290 PODD Jan 16 2026 Call Entry: $12.15 Exit: $17.62 ROI: 45% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
1iquid
1iquid Dec. 21 at 5:47 PM
💎 Liquid® Live Actionable Trade Asset: $PODD Contracts: $PODD December 18, 2026 $290 Calls Scale in: $45.02- $55.03 Scale out: $175.09-$300.15 Profit Potential : 256% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
1iquid
1iquid Dec. 20 at 5:41 PM
OptionWizards Tip (education only): Check daily trading volume on PODD, WAT, or IOT options to help ensure you can exit positions when needed. $PODD $WAT $IOT Not financial advice.
0 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 19 at 8:20 PM
Hedge Alert Live - Protect Your Portfolio Contract: $PODD $290.00 Put · JAN 16, 2026 Exp Entry Price: $7.70 - $8.09 Exit Price Target: $14.40 Profit Margin: +87% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 3:53 PM
$PODD: Actionable Trade Alert Market Context: With the last close at $292.88, $PODD is currently trading near its 60D low of $287.52, indicating potential support. The RSI at 23.35 suggests the stock is oversold, increasing the likelihood of a rebound. The MA30 and MA50 are above the current price, indicating a bearish trend in the short term, but the extreme RSI signals a potential reversal. Directional Bias: Given the oversold condition and proximity to the 60D low, we anticipate a bullish reversal. Trade Plan: - Suggested Entry: $293.00 - Stop Loss: $286.00 (below 60D low) - Take Profit Targets: 1. $305.00 (3.5% ROI) 2. $320.00 (9.3% ROI) 3. $343.00 (17% ROI) This plan leverages the oversold RSI and potential for a price recovery within the established high-low range. Monitor for price action around these levels to adjust strategy as necessary. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 19 at 9:10 AM
$PODD Current Stock Price: $292.83 Contracts to trade: $290 PODD Dec 19 2025 Call Entry: $5.13 Exit: $7.82 ROI: 52% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 2:28 PM
Truist Securities has updated their rating for Insulet ( $PODD ) to Buy with a price target of 390.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 8:06 PM
Canaccord Genuity has adjusted their stance on Insulet ( $PODD ), setting the rating to Buy with a target price of 432 → 450.
1 · Reply
Latest News on PODD
Insulet Corporation (PODD) Analyst/Investor Day Transcript

Nov 20, 2025, 8:13 PM EST - 5 weeks ago

Insulet Corporation (PODD) Analyst/Investor Day Transcript


PODD Vs. Intuitive Surgical: This Underdog Might Just Win

Nov 12, 2025, 2:15 PM EST - 6 weeks ago

PODD Vs. Intuitive Surgical: This Underdog Might Just Win

ISRG


Insulet Corporation (PODD) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 12:46 PM EST - 7 weeks ago

Insulet Corporation (PODD) Q3 2025 Earnings Call Transcript


Insulet Reports Third Quarter 2025 Results

Nov 6, 2025, 6:30 AM EST - 7 weeks ago

Insulet Reports Third Quarter 2025 Results


Final Trades: Insulet Corp, Uber and Apollo Global

Nov 4, 2025, 1:20 PM EST - 7 weeks ago

Final Trades: Insulet Corp, Uber and Apollo Global

APO UBER


Insulet to Host Investor Day on November 20, 2025

Oct 10, 2025, 7:00 AM EDT - 2 months ago

Insulet to Host Investor Day on November 20, 2025


Insulet Announces CFO Transition

Sep 16, 2025, 7:00 AM EDT - 3 months ago

Insulet Announces CFO Transition


Insulet Elevates Eric Benjamin to Chief Operating Officer

Aug 25, 2025, 5:00 PM EDT - 4 months ago

Insulet Elevates Eric Benjamin to Chief Operating Officer


Insulet to Participate in Upcoming Investor Conferences

Aug 19, 2025, 6:00 AM EDT - 4 months ago

Insulet to Participate in Upcoming Investor Conferences


Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 11:14 AM EDT - 5 months ago

Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript


Outlier Money Flows Lift Insulet

May 14, 2025, 7:20 AM EDT - 8 months ago

Outlier Money Flows Lift Insulet


Insulet Announces Publication of 2024 Sustainability Report

May 13, 2025, 6:00 AM EDT - 8 months ago

Insulet Announces Publication of 2024 Sustainability Report


Insulet Is the Top S&P 500 Performer Today. Here's Why.

May 9, 2025, 10:11 AM EDT - 8 months ago

Insulet Is the Top S&P 500 Performer Today. Here's Why.


Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:35 PM EDT - 8 months ago

Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript


Insulet beats quarterly profit estimates on insulin pump demand

May 8, 2025, 4:28 PM EDT - 8 months ago

Insulet beats quarterly profit estimates on insulin pump demand


Insulet Names New CEO, Expects to Top Revenue Projections

Apr 28, 2025, 10:26 AM EDT - 8 months ago

Insulet Names New CEO, Expects to Top Revenue Projections


1iquid
1iquid Dec. 25 at 4:56 PM
💎 Liquid® Live Actionable Trade Asset: $PODD Contracts: $PODD December 18, 2026 $290 Calls Scale in: $43.72- $53.43 Scale out: $170.01-$291.45 Profit Potential : 209% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 1:59 PM
$PODD: Current market context shows a bearish trend with last close at $288.82 and an RSI of 23.42, indicating oversold conditions. The stock is trading below both the 30-day MA of $310.53 and the 50-day MA of $314.55, reinforcing the downward pressure. However, with a 60-day high of $354.88 and a low of $285.02, there’s potential for a rebound. Directional bias is cautiously bullish due to the extreme RSI, suggesting a possible reversal. Suggested entry: $290.00. Stop loss: $285.00 (below the 60D low). Take profit targets: 1. $310.00 (TP1, 6.9% ROI) 2. $320.00 (TP2, 10.1% ROI) 3. $338.00 (TP3, 17% ROI) This plan capitalizes on the potential for a bounce back from oversold conditions while maintaining a disciplined risk management approach. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 24 at 10:03 AM
$PODD Current Stock Price: $285.45 Contracts to trade: $290 PODD Jan 16 2026 Call Entry: $12.15 Exit: $17.62 ROI: 45% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
1iquid
1iquid Dec. 21 at 5:47 PM
💎 Liquid® Live Actionable Trade Asset: $PODD Contracts: $PODD December 18, 2026 $290 Calls Scale in: $45.02- $55.03 Scale out: $175.09-$300.15 Profit Potential : 256% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
1iquid
1iquid Dec. 20 at 5:41 PM
OptionWizards Tip (education only): Check daily trading volume on PODD, WAT, or IOT options to help ensure you can exit positions when needed. $PODD $WAT $IOT Not financial advice.
0 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 19 at 8:20 PM
Hedge Alert Live - Protect Your Portfolio Contract: $PODD $290.00 Put · JAN 16, 2026 Exp Entry Price: $7.70 - $8.09 Exit Price Target: $14.40 Profit Margin: +87% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 3:53 PM
$PODD: Actionable Trade Alert Market Context: With the last close at $292.88, $PODD is currently trading near its 60D low of $287.52, indicating potential support. The RSI at 23.35 suggests the stock is oversold, increasing the likelihood of a rebound. The MA30 and MA50 are above the current price, indicating a bearish trend in the short term, but the extreme RSI signals a potential reversal. Directional Bias: Given the oversold condition and proximity to the 60D low, we anticipate a bullish reversal. Trade Plan: - Suggested Entry: $293.00 - Stop Loss: $286.00 (below 60D low) - Take Profit Targets: 1. $305.00 (3.5% ROI) 2. $320.00 (9.3% ROI) 3. $343.00 (17% ROI) This plan leverages the oversold RSI and potential for a price recovery within the established high-low range. Monitor for price action around these levels to adjust strategy as necessary. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 19 at 9:10 AM
$PODD Current Stock Price: $292.83 Contracts to trade: $290 PODD Dec 19 2025 Call Entry: $5.13 Exit: $7.82 ROI: 52% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 2:28 PM
Truist Securities has updated their rating for Insulet ( $PODD ) to Buy with a price target of 390.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 8:06 PM
Canaccord Genuity has adjusted their stance on Insulet ( $PODD ), setting the rating to Buy with a target price of 432 → 450.
1 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 2:40 AM
$PODD: Current market context shows a significant oversold condition with an RSI of 17.97, indicating potential for a reversal. The last close at $288.68 is near the 60D low of $287.52, suggesting strong support. The MA30 and MA50 are both above the current price, indicating bearish momentum, but the extreme RSI signals a potential bounce. Directional bias is bullish due to the oversold RSI. Suggested entry is at $290.00, with a stop loss set at $284.00 (below the 60D low). Take Profit Targets: 1. TP1: $300.00 (3.45% gain) 2. TP2: $310.00 (6.89% gain) 3. TP3: $338.00 (16.89% gain) Target 3 offers a potential ROI of 17% or more, aligning with the 60D high of $354.88. This trade plan capitalizes on the oversold condition while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 16 at 8:14 PM
Hedge Alert Live - Protect Your Portfolio Contract: $PODD $280.00 Put · JAN 16, 2026 Exp Entry Price: $5.75 - $7.90 Exit Price Target: $9.49 Profit Margin: +65% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 16 at 1:58 PM
Evercore ISI Group has updated their rating for Insulet ( $PODD ) to Outperform with a price target of 370.
0 · Reply
JInvestTrade
JInvestTrade Dec. 16 at 1:45 AM
$SENS $DXCM $ABT $PODD $TNDM https://www.linkedin.com/posts/eversense-cgm_eversense365-eversensecgm-diabetes-activity-7406347355777630210-2aXK?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
ZacksResearch
ZacksResearch Dec. 15 at 12:58 PM
MedTech stocks to watch in 2026: $ISRG, $PODD, $BSX, $IDXX 🚀 🦾 ISRG: Da Vinci systems drive expected 14.3% revenue growth in 2026, Zacks Rank #1 📈 PODD: Omnipod 5 expansion fuels 19.8% revenue boost, Zacks Rank #2 💉 BSX: WATCHMAN & FARAPULSE tech gain traction, Zacks Rank #2 🐾 IDXX: Companion Animal diagnostics thrive, Zacks Rank #2 Discover why these could outperform 👉 https://www.zacks.com/stock/news/2804170/4-medical-device-stocks-to-buy-for-healthy-returns-in-2026?cid=sm-stocktwits-2-2804170-body-24744&ADID=SYND_STOCKTWITS_TWEET_2_2804170_BODY_24744
0 · Reply
ZacksResearch
ZacksResearch Dec. 15 at 11:58 AM
Medtech’s next growth wave is taking shape — and these names are leading it 🚀 $ISRG, $PODD, $BSX and $IDXX are highlighted as leaders in medtech innovation, leveraging AI, robotics, and diagnostics as key growth drivers heading into 2026. See how each company is positioned to benefit from these technologies 👉 https://www.zacks.com/stock/news/2804170/4-medical-device-stocks-to-buy-for-healthy-returns-in-2026?cid=sm-stocktwits-2-2804170-teaser-24735&ADID=SYND_STOCKTWITS_TWEET_2_2804170_TEASER_24735
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 6:14 AM
$PODD Actionable Trade Alert: Market Context: $PODD is currently trading at $295.7, significantly below its 60-day high of $354.88, indicating potential for upward movement. The RSI at 24.93 suggests the stock is oversold, which may lead to a reversal. Both the 30-day and 50-day moving averages are around $318.50, indicating resistance levels above the current price. Directional Bias: The current oversold condition (RSI < 30) combined with the proximity to the 60-day low of $288.02 suggests a bullish reversal could be imminent. Trade Plan: - Suggested Entry: $296.00 - Stop Loss: $288.00 (below the 60D low) - Take Profit Targets: 1. $310.00 (5% gain) 2. $325.00 (10% gain) 3. $346.00 (17% gain) This plan offers a structured approach to capitalize on a potential rebound while maintaining a favorable risk-reward ratio. https://privateprofiteers.com
0 · Reply
melinavaughn
melinavaughn Dec. 12 at 5:26 PM
$PODD Mainz Biomed is the exact tape that can shock people later, ~310k shares short (reported) against a micro float setup, any sustained bid can force ugly covering
0 · Reply
TrevPhil13
TrevPhil13 Dec. 12 at 1:49 PM
$PODD They have updated algorithm coming soon and libre 3 integration. They don't have any real competitors at the moment. This should go only up from here.
0 · Reply
Ggeetz
Ggeetz Dec. 12 at 2:21 AM
$PODD Down after hours also.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:07 PM
$PODD: Actionable Trade Alert Market Context: With the last close at $293.59, $PODD is currently trading below its 30-day (MA30) and 50-day (MA50) moving averages, indicating bearish momentum. The RSI at 39.04 suggests the stock is approaching oversold territory, which may present a buying opportunity as it could rebound. Directional Bias: The stock is within a range defined by the 60-day high of $354.88 and low of $288.02. Given the current price, there is potential for a reversal towards the high end of this range. Trade Plan: - Suggested Entry: $295.00 (slightly above last close to confirm momentum) - Stop Loss: $288.00 (below recent low to manage risk) - Take Profit Targets: 1. $310.00 (5% gain) 2. $330.00 (12.4% gain) 3. $344.00 (17.2% gain) This plan allows for a structured approach with a clear risk-reward ratio. Monitor closely for momentum shifts. https://privateprofiteers.com
0 · Reply
harper_bailey14
harper_bailey14 Dec. 11 at 8:12 PM
$PODD Mainz Biomed is the definition of easy-to-move microcap: one news pop + 5x volume and this can go 1.05 → 1.25 in a straight line while everyone else is still refreshing their screen 🚀
0 · Reply